Issue 12, 2012

Zirconium phosphate nano-platelets: a novel platform for drug delivery in cancer therapy

Abstract

Doxorubicin was intercalated into novel zirconium phosphate nano-platelets (ZrP). The obtained doxorubicin intercalated ZrP nano-platelets had an impressive 34.9% (w/w) drug loading. We used this material to deliver doxorubicin to breast cancer cells (MCF-7). Cellular studies with MCF-7 cells showed higher uptake and cytotoxicity of doxorubicin loaded ZrP compared to free doxorubicin.

Graphical abstract: Zirconium phosphate nano-platelets: a novel platform for drug delivery in cancer therapy

Supplementary files

Article information

Article type
Communication
Submitted
06 Oct 2011
Accepted
12 Dec 2011
First published
13 Dec 2011

Chem. Commun., 2012,48, 1754-1756

Zirconium phosphate nano-platelets: a novel platform for drug delivery in cancer therapy

A. Díaz, V. Saxena, J. González, A. David, B. Casañas, C. Carpenter, J. D. Batteas, J. L. Colón, A. Clearfield and M. Delwar Hussain, Chem. Commun., 2012, 48, 1754 DOI: 10.1039/C2CC16218K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements